PGx Oncology
Pharmacogenomic (PGx) testing using Next-Generation Sequencing (NGS) analyzes how your specific genetic makeup affects your body’s response to cancer medications. It provides actionable insights to select the safest, most effective drug therapies, avoid severe adverse reactions, and optimize dosages based on your metabolizer status.
Key Concepts & Applications
Instead of testing single genes, NGS allows simultaneous analysis of multiple genes (e.g., CYP family, DPYD) involved in drug metabolism, offering a comprehensive and cost-effective approach.
- Minimizing Trial & Error: Helps personalize treatment by avoiding medications that your body may fail to metabolize or prematurely degrade.
- Actionable Guidelines: Helps physicians tailor chemotherapy and supportive care drugs to reduce adverse side effects and maximize efficacy.